This trial will compare optical coherence tomography-guided saphenous vein grafting to the standard of care in coronary artery bypass surgery to see if it reduces the rate of early vein graft failure.
1 Primary · 16 Secondary · Reporting Duration: 12 months
760 Total Participants · 2 Treatment Groups
Primary Treatment: OCT-guided saphenous vein CABG · No Placebo Group · N/A
Age 18+ · All Participants · 4 Total Inclusion CriteriaMark “Yes” if the following statements are true for you: